Harmony Gold Mining reports 61% operating profit surge but output decline and copper capex weigh on HMY stock
Can selective Bb inhibition give NovelMed Therapeutics an edge in the multibillion-dollar PNH drug market?
Read More 6 minute read Pharma Industry News NextCure brings Simcere Zaiming’s SIM0505 to U.S. trials as ADC race accelerates in oncology Find out how NextCure and Simcere Zaiming are expanding SIM0505’s Phase 1 program into the U.S. and redefining the future of ADC collaboration. bySoujanya RaviOctober 16, 2025